Who owns LIMINATUS PHARMA LLC?

Tip: Access positions for across all investors

Analyze quarterly positions in Liminatus Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Liminatus Pharma stock

Who bought or sold LIMINATUS PHARMA LLC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Aristeia Capital 320k $16k 0% Mar 2026
 View chart
Linden Advisors 268k $11k 0% Dec 2025
 View chart
Saba Capital Management 234k $12k 0% Mar 2026
 View chart
Highbridge Capital Management 159k $5.5k 10% Dec 2025
 View chart
Moore Capital Management 125k $5.0k 0% Mar 2026
 View chart
Polar Securities 123k $6.0k 0% Mar 2026
 View chart
MMCAP International Inc. SPC 112k $3.9k 0% Dec 2025
 View chart
D. E. Shaw & Co 83k $3.3k 0% Mar 2026
 View chart
Millennium Management 71k $2.8k 0% Mar 2026
 View chart
Blue Owl Capital Holdings 50k $2.0k 0% Dec 2025
 View chart
Periscope Capital 48k $1.9k 0% Mar 2026
 View chart
Wolverine Asset Management 39k $1.6k -37% Mar 2026
 View chart
Toronto-Dominion Bank 35k $1.4k 0% Mar 2026
 View chart
LMR Partners 30k $1.2k 0% Mar 2026
 View chart
Gts Securities 30k $1.0k -1% Dec 2025
 View chart
Arena Capital Advisors, LLC- CA 29k $1.2k 0% Mar 2026
 View chart
Jane Street 24k $970.960000 0% Mar 2026
 View chart
Susquehanna International 24k $836.710000 100% Dec 2025
 View chart
Limestone Investment Advisors 23k $789.670000 0% Dec 2025
 View chart
Flow Traders US 13k $1.0k 0% Mar 2026
 View chart
DuPont Capital Management Corporation 6.3k $306.250000 0% Mar 2026
 View chart
UBS Group 4.5k $179.829300 7% Mar 2026
 View chart
HGC Investment Management 1.3k $44.000000 0% Dec 2025
 View chart
Clear Street Group 100.00 $4.000000 100% Mar 2026
 View chart

Who sold out of Liminatus Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Point72 Asset Management Dec 2025 12k $434.000000